News Overview

Godawari Power and Ispat Ltd shares has witnessed a total of 42% in the last one year, and 12% since the beginning of the year.

Piramal Pharma Solutions (PPS) is set to invest $80 million in expanding its sterile injectables facility in Lexington, Kentucky, USA, projected for completion by FY27.

Gross NPA slightly increased by 2 basis points to 1.92%, while net NPA improved by 11 basis points to 0.48%.

Revenue in Q1 FY25 had also dropped by 5.10% to ₹699.14 Crore, compared to ₹736.72 Crore in the same quarter last year.

BPCL’s EBITDA was reported at ₹4,547 crore, reflecting a 19.5% decrease from the previous quarter. The EBITDA margin stood at 4.4%.

Gensol Engineering stocks has witnessed a 9.52% dip in the last one year, and 7.5% dip since the beginning of the year.

Revenue rose to ₹8,522 Crore for the July-September quarter, with ₹6,403 Crore from zinc, lead, and other segments and ₹1,550 Crore from the silver division.

Distribution record date is set for October 30, 2024, with payment expected by November 9, 2024.

EBITDA saw a 12.4% increase, standing at ₹129.5 Crore for Q2 FY25, up from ₹115.2 Crore in the previous fiscal period.

Capacity utilization for Q2 FY25 was 64% for cement production and 67% for clinker, influenced by operational disruptions at the Muddapur facility.